Olga (Olya) Morozova

Assistant Professor
Public Health Sciences
Biological Sciences Division
University of Chicago

Publications
  1. Olga Morozova, Conroy K, Riabokon S, Germanovich M, Zelinskyi Y, Puttkammer N, Dumchev K. (2025). HIV Viral Rebound on Dolutegravir, Lopinavir, and Efavirenz: National Program Data Analysis From Ukraine. JAIDS Journal of Acquired Immune Deficiency Syndromes, 99(4): 395-404. [journal]
  2. Babalola TK, Clouston SAP, Sekendiz Z, Chowdhury D, Soriolo N, Kawuki J, Meliker J, Carr M, Valenti BR, Fontana A, Melendez OA, Olga Morozova, Luft BJ. (2025). SARS-CoV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort study. The Lancet Regional Health – Americas, 42, 100984. [journal]
  3. Sekendiz Z, Olga Morozova, Carr MA, Fontana A, Mehta N, Ali A, Jiang E, Babalola T, Clouston SAP, Luft BJ. (2024). Characterization of Change in Cognition Before and After COVID-19 Infection in Essential Workers at Midlife. American Journal of Medicine Open, 12, 100076. [journal]
  4. Machavariani E, Dumchev K, Pykalo I, Filippovych M, Ivasiy R, Esserman D, Madden LM, Bromberg DJ, Haddad M, Olga Morozova, Ahmad B, Oliveros Gómez D, Farnum S, Dvoriak S, Altice FL. (2024). Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine. Contemporary Clinical Trials, 146:107690. [journal]
  5. Olga Morozova, Kornilova M, Makarenko O, Antoniak S, Liulchuk M, Varetska O, Dumchev K. (2024). Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers. Journal of the International AIDS Society, 27 (Suppl 3), e26319. [journal, open access]
  6. Owczarzak J, Monton O, Fuller S, Burlaka J, Kiriazova T, Olga Morozova, Dumchev K. (2024). “Will you need this health at all? Will you be alive?”: using the bioecological model of mass trauma to understand HIV care experiences during the war in Ukraine. Journal of the International AIDS Society, 27 (Suppl 3), e26307. [journal, open access]
  7. Olga Morozova, Dvoriak V, Dumchev K, Machavariani E, Bromberg D, Dvoriak S, Altice FL. (2024). Prevalence and Correlates of Depression and Bipolar Disorder Among Patients Maintained on Methadone and Buprenorphine in Ukraine. International Journal of Mental Health and Addiction. [journal]
  8. Zeziulin O, Kornilova M, Deac A, Olga Morozova, Varetska O, Pykalo I, Dumchev K. (2024). Modes of HIV transmission among young women and their sexual partners in Ukraine. PLOS ONE, 19(6), e0305072. [journal, open access]
  9. Fadikar A, Stevens A, Collier N, Toh KB, Olga Morozova, Hotton A, Clark J, Higdon D, Ozik J. (2024). Towards Improved Uncertainty Quantification of Stochastic Epidemic Models Using Sequential Monte Carlo. Proceedings of the IEEE International Parallel and Distributed Processing Symposium Workshops (IPDPSW). [conference proceedings]
  10. Dumchev K, Kornilova M, Makarenko O, Antoniak S, Liulchuk M, Cottrell ML, Varetska O, Olga Morozova. (2024). Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine. International Journal of Drug Policy, 123, 104284. [journal]
  11. Machavariani E, Bromberg DJ, Dumchev K, Dvoriak S, Zeziulin O, Olga Morozova, Esserman D, Pykalo I, Saichuk N, Ivasiy R, Haddad MS, Altice FL. (2023). Design, implementation and preliminary results of a type-2 hybrid cluster-randomized trial of integrating screening and treatment for major depressive disorder into specialty clinics providing opioid agonist therapies in Ukraine. Contemporary Clinical Trials, 131, 107248. [journal]
  12. Olga Morozova, Ivanchuk I, Gvozdetska O, Nesterova O, Skala P, Kuzin I, Dumchev K. (2023). Treatment of opioid use disorder in Ukraine during the first year of the Russia–Ukraine war: Lessons learned from the crisis. International Journal of Drug Policy, 117, 104062. [journal] [open access]
  13. Waszczuk MA, Olga Morozova, Lhuillier E, Docherty AR, Shabalin AA, Yang X, Carr MA, Clouston SA, Kotov R, Luft BJ. (2023). Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders. PLOS One, 18(3), e0282271. [journal]
  14. Kushakov V, Dvoriak V, Olga Morozova, Azbel L, Sergienko G. (2022). Psychoactive substance use and drug checking practices among participants at electronic dance music events in Ukraine. Drugs, Habits and Social Policy, 23(3), 244-257. [journal]
  15. Pashchenko O, Bromberg DJ, Dumchev K, LaMonaca K, Pykalo I, Filippovych M, Esserman D, Polonsky M, Galvez de Leon SJ, Olga Morozova, Dvoriak S, Altice FL. (2022). Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial. PLOS Global Public Health, 2(11), e0000344. [journal]
  16. Eck DJ, Olga Morozova, Crawford FW. (2022). Randomization for the susceptibility effect of an infectious disease intervention. Journal of Mathematical Biology, 85, 37. [journal]
  17. Lhuillier E, Yang Y, Olga Morozova, Clouston SA, Yang X, Waszczuk MA, Carr MA, Luft BJ. (2022). The Impact of World Trade Center Related Medical Conditions on the Severity of COVID-19 Disease and Its Long-Term Sequelae. International Journal of Environmental Research and Public Health, 19(12), 6963. [journal]
  18. Crawford FW, Jones SA, Cartter M, Dean SG, Warren JL, Li ZR, Barbieri J, Campbell J, Kenney P, Valleau T, Olga Morozova. (2022). Impact of close interpersonal contact on COVID-19 incidence: Evidence from 1 year of mobile device data. Science Advances, 8(1), eabi5499. [journal]
  19. Olga Morozova, Li ZR, Crawford FW. (2021). One year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut. Scientific Reports, 11(1), 1-14. [journal]
  20. Clouston SA, Olga Morozova, Meliker JR. (2021). A wind speed threshold for increased outdoor transmission of coronavirus: an ecological study. BMC Infectious Diseases, 21(1), 1-9. [journal]
  21. Olga Morozova, Clouston SA, Valentine J, Newman A, Carr M, Luft BJ. (2021). COVID-19 cumulative incidence, asymptomatic infections, and fatality in Long Island, NY, January–August 2020: A cohort of World Trade Center responders. PLOS One, 16(7), e0254713. [journal]
  22. Olga Morozova, Crawford FW, Cohen T, Paltiel AD, Altice FL. (2020). Cost‐effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: Dynamic modeling analysis. Addiction, 115(3), 437-450. [journal] [repo]
  23. Olga Morozova, Booth RE, Dvoriak S, Dumchev K, Sazonova Y, Salyuk T, Crawford FW. (2019). Divergent estimates of HIV incidence among people who inject drugs in Ukraine. International Journal of Drug Policy, 73, 156-162. [journal]
  24. Crawford FW, Olga Morozova, Buchanan AL, Spiegelman D. (2019). Interpretation of the individual effect under treatment spillover. American Journal of Epidemiology, 188(8), 1407–1409. [journal]
  25. LaMonaca K, Dumchev K, Dvoriak S, Azbel L, Olga Morozova, Altice FL. (2019). HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy. Current Psychiatry Reports, 21(7), 47. [journal]
  26. Rutledge R, Olga Morozova, Gibson BA, Altice FL, Kamarulzaman A, Wickersham JA. (2018). Correlates of recent HIV testing among transgender women in Greater Kuala Lumpur, Malaysia. LGBT Health, 5(8), 484-493. [journal]
  27. Rozanova J*, Olga Morozova*, Azbel L, Bachireddy C, Izenberg JM, Kiriazova T, Dvoryak S, Altice FL. (2018). Perceptions of Health-Related Community Reentry Challenges among Incarcerated Drug Users in Azerbaijan, Kyrgyzstan, and Ukraine. Journal of Urban Health, 95(4), 508-522. [journal]
    *equal contributions
  28. Olga Morozova, Cohen T, Crawford FW. (2018). Risk ratios for contagious outcomes. Journal of The Royal Society Interface, 15(138), 20170696. [journal]
  29. Dumchev K, Dvoryak S, Chernova O, Olga Morozova, Altice FL. (2017). Retention in medication-assisted treatment programs in Ukraine — Identifying factors contributing to a continuing HIV epidemic. International Journal of Drug Policy, 48, 44-53. [journal]
  30. Olga Morozova, Dvoriak S, Pykalo I, Altice FL. (2017). Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine. Drug and Alcohol Dependence, 173, 132-138. [journal]
  31. Olga Morozova, Levina O, Uusküla A, Heimer R. (2015). Comparison of subset selection methods in linear regression in the context of health-related quality of life and substance abuse in Russia. BMC Medical Research Methodology, 15(1), 71. [journal]
  32. Olga Morozova, Dvoryak S, Altice FL. (2013). Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine. International Journal of Drug Policy, 24(6), e91-e98. [journal]
  33. Olga Morozova, Azbel L, Grishaev Y, Dvoryak S, Wickersham JA, Altice FL. (2013). Ukrainian prisoners and community reentry challenges: implications for transitional care. International Journal of Prisoner Health, 9(1), 5-19. [journal]